IUS Publications

Found 9 results
Filters: Author is Esma Bilajac  [Clear All Filters]
2024
M. Dedić, Omeragić, E., Imamović, B., Bilajac, E., Mahmutović, L., Glamočlija, U., and Bečić, E., “HPLC method for the determination of thymoquinone in growth cell medium”, Technology and Health Care, vol. Pre-press, pp. 1-14, 2024.
2023
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Špirtović-Halilović, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, vol. 96, 2023.
E. Bilajac, Glamočlija, U., Osmanović, A., Mahmutovic, L., Sezer, A., Roca, S., Salihović, M., Hromic-Jahjefendic, A., and Veljović, E., “Analysis of Antitumor Potential of Xanthene Compounds in Lymphoma Cells”, Croatica Chemica Acta, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., “COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity”, Cellular Signaling, 2023.
K. Lundstrom, Hromic-Jahjefendic, A., and Bilajac, E., “COVID-19 signalome: Potential therapeutic interventions”, Cellular Signaling, vol. 103, 2023.
2022
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M. M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, vol. 13, 2022.
E. Bilajac, Mahmutovic, L., Glamočlija, U., Osmanović, A., Hromic-Jahjefendic, A., Tambuwala, M., and Suljagic, M., “Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines”, MDPI Metabolites, 2022.
E. Bilajac, Mahmutovic, L., Lundstrom, K., Glamočloja, U., Šutković, J., Sezer, A., and Hromic-Jahjefendic, A., “Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis”, MDPI Viruses, 2022.
2021
L. Mahmutovic, “Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials”, Microorganisms, vol. 9, 2021.